Volifil dermal fillers leverage innovative 'HCCL™ technology,' combining minimized BDDE, low temperature, long-time crosslinking, and a patented PP process. This advanced technique creates a stable 3D matrix, ensuring optimal crosslinking, superior volume retention, and an ideal viscosity for each model. Volifil fillers provide both high safety and effective results by minimizing foreign body responses. Product Specifications: Main Ingredients: 24 mg/ml hyaluronic acid (HA) with lidocaine 0.3% Packing Unit: 1 x 1.1 ml prefilled syringe 2 x needles
Volifil dermal fillers leverage innovative 'HCCL™ technology,' combining minimized BDDE, low temperature, long-time crosslinking, and a patented PP process. This advanced technique creates a stable 3D matrix, ensuring optimal crosslinking, superior volume retention, and an ideal viscosity for each model. Volifil fillers provide both high safety and effective results by minimizing foreign body responses. Product Specifications: Main Ingredients: 24 mg/ml hyaluronic acid (HA) with lidocaine 0.3% Packing Unit: 1 x 1.1 ml prefilled syringe 2 x needles
Volifil dermal fillers leverage innovative 'HCCL™ technology,' combining minimized BDDE, low temperature, long-time crosslinking, and a patented PP process. This advanced technique creates a stable 3D matrix, ensuring optimal crosslinking, superior volume retention, and an ideal viscosity for each model. Volifil fillers provide both high safety and effective results by minimizing foreign body responses. Product Specifications: Main Ingredients: 24 mg/ml hyaluronic acid (HA) with lidocaine 0.3% Packing Unit: 1 x 1.1 ml prefilled syringe 2 x needles